DR. BARBARA GITLITZ, M.D.
Osteopathic Medicine at Eastlake Ave, Los Angeles, CA
License number
California G70326
Category
Osteopathic Medicine
Type
Medical Oncology
Address
Address
1441 Eastlake Ave, Los Angeles, CA 90089
Phone
(323) 865-3105
Personal information
See more information about BARBARA GITLITZ at radaris.comName
Address
Phone
11347 Nebraska Ave, Los Angeles, CA 90025
330 Avenue 42, Los Angeles, CA 90065
330 W Avenue 42, Los Angeles, CA 90065
330 W Avenue 42, Los Angeles, CA 90065
Organization information
See more information about BARBARA GITLITZ at bizstanding.comBarbara Gitlitz MD
1520 San Pablo St, Los Angeles, CA 90033
Industry:
Internist
Phone:
(323) 442-5100 (Phone)
Barbara Jennifer Gitlitz
Professional information
Barbara J Gitlitz, Los Angeles CA
Specialties:
Oncologist
Address:
1441 Eastlake Ave, Los Angeles, CA 90089
Education:
State University of New York, School of Medicine (Stony Brook) - Doctor of Medicine
Ronald Reagan UCLA Medical Center - Fellowship - Hematology and Oncology (Internal Medicine)
Ronald Reagan UCLA Medical Center - Fellowship - Hematology and Oncology (Internal Medicine)
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Oncology (Internal Medicine)
Dr. Barbara J Gitlitz, Los Angeles CA - MD (Doctor of Medicine)
Specialties:
Oncology, Medical Oncology
Address:
1441 Eastlake Ave SUITE 7416, Los Angeles 90089
(323) 865-3000 (Phone)
(323) 865-3000 (Phone)
Certifications:
Internal Medicine, 2005, Medical Oncology, 2007
Awards:
Healthgrades Honor Roll
Languages:
English, Spanish
Hospitals:
1441 Eastlake Ave SUITE 7416, Los Angeles 90089
Ronald Reagan UCLA Medical Center
757 Westwood Plz, Los Angeles 90095
USC Norris Comprehensive Cancer Center
1441 Eastlake Ave, Los Angeles 90089
Ronald Reagan UCLA Medical Center
757 Westwood Plz, Los Angeles 90095
USC Norris Comprehensive Cancer Center
1441 Eastlake Ave, Los Angeles 90089
Education:
Medical School
Stony Brook Univ Health Sciences Center School Of Medicine
Graduated: 1989
UCLA
Graduated: 1990
Cedars Sinai Med Center
Graduated: 1992
Graduated: 1995
Stony Brook Univ Health Sciences Center School Of Medicine
Graduated: 1989
UCLA
Graduated: 1990
Cedars Sinai Med Center
Graduated: 1992
Graduated: 1995
Barbara Jennifer Gitlitz, Los Angeles CA
Specialties:
Internal Medicine, Medical Oncology, Plastic Surgery Within the Head and Neck, Public Health & General Preventive Medicine
Work:
USC Care Medical Group Inc.
1441 Eastlake Ave, Los Angeles, CA 90089 USC University Hospital
1500 San Pablo St, Los Angeles, CA 90033
1441 Eastlake Ave, Los Angeles, CA 90089 USC University Hospital
1500 San Pablo St, Los Angeles, CA 90033
Education:
Stony Brook University (1989)
Methods For Enhancing Antigen-Presenting Cells And Anti-Tumor Responses In A Human Patient
US Patent:
6838081, Jan 4, 2005
Filed:
Apr 2, 1999
Appl. No.:
09/647248
Inventors:
Michael Derek Roth - Los Angeles CA, US
Robert Alan Figlin - Los Angeles CA, US
Sylvia Marie Kiertscher - Los Angeles CA, US
Barbara Jennifer Gitlitz - Los Angeles CA, US
Robert Alan Figlin - Los Angeles CA, US
Sylvia Marie Kiertscher - Los Angeles CA, US
Barbara Jennifer Gitlitz - Los Angeles CA, US
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
A01N 6300, A61K 4500, A61K 3819, C12N 501, C12N 508
US Classification:
424 937, 424 9371, 424 852, 424 857, 435372, 435355, 435366, 435374, 435377, 435384, 435386, 435423
Abstract:
The present invention provides methods for enhancing the development of APC from precursor cells by administering a combination of GM-CSF and IL-4. The precursor cells include: cells contained in peripheral blood, CD cells and precursors in bone marrow. Thus, administration of GM-CSF and IL-4 can be used as a form of cytokine immunotherapy. One embodiment of the present invention involves systemic administration of GM-CSF and IL-4. In this embodiment, APC are required to directly access tumor antigens as they exist in vivo within the patient. A further embodiment of the present invention involves co-administration of a tumor-associated or tumor-specific antigen, with GM-CSF and IL-4, to induce antigen-specific immunity mediated by APC. Yet another embodiment of the present invention describes systemic administration of GM-CSF and IL-4 to achieve reduced tumor burden.